{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:18:58Z","timestamp":1791872338065,"version":"4.3.4"},"reference-count":191,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ymthe.2024.11.011","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T04:14:38Z","timestamp":1730952878000},"page":"32-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Novel insights into the ROCK-JAK-STAT signaling pathway in upper respiratory tract infections and neurodegenerative diseases"],"prefix":"10.1016","volume":"33","author":[{"given":"Jiaxuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naihui","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuli","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9469-0991","authenticated-orcid":false,"given":"Keda","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.11.011_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00103-20","article-title":"Viral Respiratory Pathogens and Lung Injury","volume":"34","author":"Clementi","year":"2021","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ymthe.2024.11.011_bib2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/d41586-018-01070-w","article-title":"Science must get ready for the next global flu crisis","volume":"553","author":"No author","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.11.011_bib3","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1016\/S1473-3099(18)30359-1","article-title":"Unanswered questions about the 1918 influenza pandemic: origin, pathology, and the virus itself","volume":"18","author":"Oxford","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ymthe.2024.11.011_bib4","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1016\/j.athoracsur.2019.02.035","article-title":"Lung Transplantation in Pulmonary Fibrosis Secondary to Influenza A Pneumonia","volume":"108","author":"Wang","year":"2019","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.ymthe.2024.11.011_bib5","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.drudis.2021.10.016","article-title":"Calming the cytokine storm of COVID-19 through inhibition of JAK2\/STAT3 signaling","volume":"27","author":"Gajjela","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ymthe.2024.11.011_bib6","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.1128\/JVI.00365-12","article-title":"Integrated clinical, pathologic, virologic, and transcriptomic analysis of H5N1 influenza virus-induced viral pneumonia in the rhesus macaque","volume":"86","author":"Shinya","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mam.2018.08.004","article-title":"Developmental pathways in the pathogenesis of lung fibrosis","volume":"65","author":"Chanda","year":"2019","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.ymthe.2024.11.011_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104673","article-title":"The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options","volume":"150","author":"Choudhary","year":"2021","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ymthe.2024.11.011_bib9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","article-title":"COVID-19: immunopathology and its implications for therapy","volume":"20","author":"Cao","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001107","article-title":"Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis","volume":"2","author":"Hueber","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2024.11.011_bib11","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/cns.12405","article-title":"Increasing the Permeability of the Blood-brain Barrier in Three Different Models in\u00a0vivo","volume":"21","author":"Liu","year":"2015","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ymthe.2024.11.011_bib12","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12974-021-02308-7","article-title":"CD4+ effector T\u00a0cells accelerate Alzheimer's disease in mice","volume":"18","author":"Machhi","year":"2021","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.ymthe.2024.11.011_bib13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe3600","article-title":"Microglial Calhm2 regulates neuroinflammation and contributes to Alzheimer's disease pathology","volume":"7","author":"Cheng","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2024.11.011_bib15","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41586-021-04136-4","article-title":"Antigen-presenting innate lymphoid cells orchestrate neuroinflammation","volume":"600","author":"Grigg","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.11.011_bib16","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2024.11.011_bib17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/ars.2020.8076","article-title":"Inflammation in Neurological Disorders: The Thin Boundary Between Brain and Periphery","volume":"33","author":"Cervellati","year":"2020","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ymthe.2024.11.011_bib18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0140-6736(22)00982-5","article-title":"Influenza","volume":"400","author":"Uyeki","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2024.11.011_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g2548","article-title":"Neuraminidase inhibitors for influenza","volume":"348","author":"Krumholz","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ymthe.2024.11.011_bib20","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.drudis.2020.06.004","article-title":"Oseltamivir analogs with potent anti-influenza virus activity","volume":"25","author":"Kumar","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ymthe.2024.11.011_bib21","first-page":"85","article-title":"Combined pirfenidone, azithromycin and prednisolone in post-H1N1 ARDS pulmonary fibrosis","volume":"35","author":"Saha","year":"2018","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.ymthe.2024.11.011_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/cmi.2015.74","article-title":"The cytokine storm of severe influenza and development of immunomodulatory therapy","volume":"13","author":"Liu","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib23","first-page":"161","article-title":"Cytokines in the systemic inflammatory response syndrome: a review","volume":"2","author":"Jaffer","year":"2010","journal-title":"HSR Proc. Intensive Care Cardiovasc. Anesth."},{"key":"10.1016\/j.ymthe.2024.11.011_bib24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12985-020-01415-w","article-title":"Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents","volume":"17","author":"Khadke","year":"2020","journal-title":"Virol. J."},{"key":"10.1016\/j.ymthe.2024.11.011_bib25","doi-asserted-by":"crossref","DOI":"10.1186\/cc9324","article-title":"Clinical aspects and cytokine response in severe H1N1 influenza A virus infection","volume":"14","author":"Hagau","year":"2010","journal-title":"Crit. Care"},{"key":"10.1016\/j.ymthe.2024.11.011_bib26","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2024.11.011_bib27","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ymthe.2024.11.011_bib28","doi-asserted-by":"crossref","first-page":"e00165-13","DOI":"10.1128\/mBio.00165-13","article-title":"Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus","volume":"4","author":"Josset","year":"2013","journal-title":"mBio"},{"key":"10.1016\/j.ymthe.2024.11.011_bib29","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.ymthe.2024.11.011_bib30","first-page":"2526","article-title":"Acute respiratory distress syndrome: the Berlin Definition","volume":"307","author":"Ranieri","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ymthe.2024.11.011_bib31","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00281-017-0639-8","article-title":"Cytokine storm and sepsis disease pathogenesis","volume":"39","author":"Chousterman","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib32","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2024.11.011_bib33","doi-asserted-by":"crossref","first-page":"R167","DOI":"10.1186\/cc9259","article-title":"Host adaptive immunity deficiency in severe pandemic influenza","volume":"14","author":"Bermejo-Martin","year":"2010","journal-title":"Crit. Care"},{"key":"10.1016\/j.ymthe.2024.11.011_bib34","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1183\/09031936.00196412","article-title":"The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance","volume":"43","author":"Burnham","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ymthe.2024.11.011_bib35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12931-018-0730-2","article-title":"Idiopathic pulmonary fibrosis: pathogenesis and management","volume":"19","author":"Sgalla","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.ymthe.2024.11.011_bib36","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMra2005230","article-title":"Spectrum of fibrotic lung diseases","volume":"383","author":"Wijsenbeek","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.11.011_bib37","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0194-2021","article-title":"Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection","volume":"30","author":"Mylvaganam","year":"2021","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.ymthe.2024.11.011_bib38","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.it.2020.10.004","article-title":"Mechanisms of SARS-CoV-2 Transmission and Pathogenesis","volume":"41","author":"Harrison","year":"2020","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib39","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1513\/pats.201201-003AW","article-title":"TGF-\u03b2 activation and lung fibrosis","volume":"9","author":"Tatler","year":"2012","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.ymthe.2024.11.011_bib40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.immuni.2011.02.012","article-title":"Functional specialization of interleukin-17 family members","volume":"34","author":"Iwakura","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2024.11.011_bib41","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20092121","article-title":"Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent","volume":"207","author":"Wilson","year":"2010","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2024.11.011_bib42","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1007\/s10753-019-01010-4","article-title":"Acute Lung Injury: IL-17A-Mediated Inflammatory Pathway and Its Regulation by Curcumin","volume":"42","author":"Gouda","year":"2019","journal-title":"Inflammation"},{"key":"10.1016\/j.ymthe.2024.11.011_bib43","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1038\/s41467-019-09883-7","article-title":"IL-1\u03b2, IL-23, and TGF-\u03b2 drive plasticity of human ILC2s towards IL-17-producing ILCs in nasal inflammation","volume":"10","author":"Golebski","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.11.011_bib44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cytogfr.2020.06.013","article-title":"The potential of JAK\/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19","volume":"54","author":"Goker Bagca","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ymthe.2024.11.011_bib45","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2024.11.011_bib46","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","article-title":"JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects","volume":"77","author":"Banerjee","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.ymthe.2024.11.011_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72305-y","article-title":"Th17\/Treg imbalance in COPD development: suppressors of cytokine signaling and signal transducers and activators of transcription proteins","volume":"10","author":"Silva","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2024.11.011_bib48","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1146\/annurev.immunol.25.022106.141557","article-title":"IL-17 family cytokines and the expanding diversity of effector T\u00a0cell lineages","volume":"25","author":"Weaver","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib49","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1164\/rccm.201102-0236OC","article-title":"The Th17 pathway in cystic fibrosis lung disease","volume":"184","author":"Tan","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymthe.2024.11.011_bib50","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.4049\/jimmunol.1400181","article-title":"IL-17A influences essential functions of the monocyte\/macrophage lineage and is involved in advanced murine and human atherosclerosis","volume":"193","author":"Erbel","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib51","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/ni.1663","article-title":"Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T\u00a0cells","volume":"9","author":"Zhang","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib52","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/cr.2014.154","article-title":"STAT5 programs a distinct subset of GM-CSF-producing T helper cells that is essential for autoimmune neuroinflammation","volume":"24","author":"Sheng","year":"2014","journal-title":"Cell Res."},{"key":"10.1016\/j.ymthe.2024.11.011_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.563850","article-title":"Innate Immunity and Influenza A Virus Pathogenesis: Lessons for COVID-19","volume":"10","author":"Hartshorn","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib54","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nri2606","article-title":"Rho family GTPases and their regulators in lymphocytes","volume":"9","author":"Tybulewicz","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35109-9","article-title":"ROCK2, but not ROCK1 interacts with phosphorylated STAT3 and co-occupies TH17\/TFH gene promoters in TH17-activated human T\u00a0cells","volume":"8","author":"Chen","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2024.11.011_bib56","article-title":"ROCK2 inhibition attenuates profibrogenic immune cell function to reverse thioacetamide-induced liver fibrosis","volume":"4","author":"Nalkurthi","year":"2022","journal-title":"JHEP Rep."},{"key":"10.1016\/j.ymthe.2024.11.011_bib57","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2119\/molmed.2016.00041","article-title":"RhoA\/ROCK signaling regulates TGF\u03b2-induced epithelial-mesenchymal transition of lens epithelial cells through MRTF-A","volume":"22","author":"Korol","year":"2016","journal-title":"Mol. Med."},{"key":"10.1016\/j.ymthe.2024.11.011_bib58","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1165\/rcmb.2016-0306OC","article-title":"Role of Rho-Associated Coiled-Coil Forming Kinase Isoforms in Regulation of Stiffness-Induced Myofibroblast Differentiation in Lung Fibrosis","volume":"56","author":"Htwe","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib59","doi-asserted-by":"crossref","first-page":"C133","DOI":"10.1152\/ajpcell.00067.2022","article-title":"DOCK2 contributes to pulmonary fibrosis by promoting lung fibroblast to myofibroblast transition","volume":"323","author":"Guo","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib60","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrm2890","article-title":"Linking actin dynamics and gene transcription to drive cellular motile functions","volume":"11","author":"Olson","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib61","doi-asserted-by":"crossref","first-page":"L190","DOI":"10.1152\/ajplung.00086.2022","article-title":"Myofibroblast-specific inhibition of the Rho kinase-MRTF-SRF pathway using nanotechnology for the prevention of pulmonary fibrosis","volume":"324","author":"Knipe","year":"2023","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib62","doi-asserted-by":"crossref","first-page":"16850","DOI":"10.1073\/pnas.1316764110","article-title":"Activation of MRTF-A-dependent gene expression with a small molecule promotes myofibroblast differentiation and wound healing","volume":"110","author":"Velasquez","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.11.011_bib63","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cca.2012.08.013","article-title":"BACE1 in Alzheimer's disease","volume":"414","author":"Sathya","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymthe.2024.11.011_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/biom11101508","article-title":"Mitochondrial Dysfunction, Protein Misfolding and Neuroinflammation in Parkinson's Disease: Roads to Biomarker Discovery","volume":"11","author":"Picca","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ymthe.2024.11.011_bib65","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3233\/JAD-210268","article-title":"NLRP3 Inflammasome: A Starring Role in Amyloid-\u03b2- and Tau-Driven Pathological Events in Alzheimer's Disease","volume":"83","author":"Van Zeller","year":"2021","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.ymthe.2024.11.011_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.566922","article-title":"Interleukin-17A: The Key Cytokine in Neurodegenerative Diseases","volume":"12","author":"Chen","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ymthe.2024.11.011_bib67","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/14728222.2019.1590336","article-title":"Th17 cells: a promising therapeutic target for Parkinson's disease?","volume":"23","author":"Prots","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ymthe.2024.11.011_bib68","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMra052130","article-title":"Multiple sclerosis--the plaque and its pathogenesis","volume":"354","author":"Frohman","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.11.011_bib69","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11481-019-09852-3","article-title":"Dopaminergic Therapeutics in Multiple Sclerosis: Focus on Th17-Cell Functions","volume":"15","author":"Melnikov","year":"2020","journal-title":"J.\u00a0Neuroimmune Pharmacol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib70","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jns.2013.03.002","article-title":"Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination","volume":"333","author":"Rostami","year":"2013","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.ymthe.2024.11.011_bib71","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/s41418-021-00910-z","article-title":"Ferroptosis mediates selective motor neuron death in amyotrophic lateral sclerosis","volume":"29","author":"Wang","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ymthe.2024.11.011_bib72","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib73","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer's disease","volume":"217","author":"Hansen","year":"2018","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib74","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","article-title":"Neuroinflammation in Alzheimer's disease: Current evidence and future directions","volume":"12","author":"Calsolaro","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.ymthe.2024.11.011_bib75","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuint.2018.07.003","article-title":"Recent advances in the mechanisms of neuroinflammation and their roles in neurodegeneration","volume":"120","author":"Niranjan","year":"2018","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ymthe.2024.11.011_bib76","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/nn.2887","article-title":"Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool","volume":"14","author":"Ajami","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymthe.2024.11.011_bib77","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbi.2016.03.009","article-title":"Multiple inflammasome complexes are activated in autistic spectrum disorders","volume":"57","author":"Saresella","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ymthe.2024.11.011_bib78","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","article-title":"Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease","volume":"153","author":"Zhang","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2024.11.011_bib79","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-510X(03)00203-X","article-title":"Differential expression and regulation of IL-23 and IL-12 subunits and receptors in adult mouse microglia","volume":"215","author":"Li","year":"2003","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.ymthe.2024.11.011_bib80","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature13152","article-title":"NRROS negatively regulates reactive oxygen species during host defence and autoimmunity","volume":"509","author":"Noubade","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.11.011_bib81","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1517\/14728220903213426","article-title":"Targeting the JAK2\/STAT3 axis in Alzheimer's disease","volume":"13","author":"Chiba","year":"2009","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ymthe.2024.11.011_bib82","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/mp.2008.105","article-title":"Amyloid-beta causes memory impairment by disturbing the JAK2\/STAT3 axis in hippocampal neurons","volume":"14","author":"Chiba","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ymthe.2024.11.011_bib83","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.neurobiolaging.2006.02.012","article-title":"Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease","volume":"28","author":"Alvarez","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ymthe.2024.11.011_bib84","doi-asserted-by":"crossref","first-page":"6548","DOI":"10.1007\/s12035-015-9556-9","article-title":"Folic Acid Alters Methylation Profile of JAK-STAT and Long-Term Depression Signaling Pathways in Alzheimer's Disease Models","volume":"53","author":"Li","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib85","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1523\/JNEUROSCI.5321-06.2007","article-title":"Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons","volume":"27","author":"Mount","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2024.11.011_bib86","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/aje\/kwm260","article-title":"Peripheral inflammatory biomarkers and risk of Parkinson's disease","volume":"167","author":"Chen","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib87","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002488","article-title":"Biomarkers for Parkinson's disease","volume":"3","author":"Sherer","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2024.11.011_bib88","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1523\/JNEUROSCI.4658-15.2016","article-title":"Inhibition of the JAK\/STAT Pathway Protects\u00a0Against \u03b1-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration","volume":"36","author":"Qin","year":"2016","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2024.11.011_bib89","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nn.2829","article-title":"Interferon-\u03b3 induces progressive nigrostriatal degeneration and basal ganglia calcification","volume":"14","author":"Chakrabarty","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymthe.2024.11.011_bib90","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1038\/ncomms4633","article-title":"MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration","volume":"5","author":"Cebri\u00e1n","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.11.011_bib91","doi-asserted-by":"crossref","first-page":"16463","DOI":"10.1523\/JNEUROSCI.2131-15.2015","article-title":"Selective VIP Receptor Agonists Facilitate Immune Transformation for Dopaminergic Neuroprotection in MPTP-Intoxicated Mice","volume":"35","author":"Olson","year":"2015","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2024.11.011_bib92","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nri2356","article-title":"Colony-stimulating factors in inflammation and autoimmunity","volume":"8","author":"Hamilton","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib93","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.4049\/jimmunol.161.12.6480","article-title":"IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T\u00a0cells","volume":"161","author":"Samoilova","year":"1998","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib94","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","article-title":"Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain","volume":"421","author":"Cua","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.11.011_bib95","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.1073\/pnas.1117218109","article-title":"Signal transducer and activator of transcription-3\/suppressor of cytokine signaling-3 (STAT3\/SOCS3) axis in myeloid cells regulates neuroinflammation","volume":"109","author":"Qin","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.11.011_bib96","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","article-title":"Alternative activation of macrophages: mechanism and functions","volume":"32","author":"Gordon","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2024.11.011_bib97","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.immuni.2005.10.001","article-title":"Macrophage polarization comes of age","volume":"23","author":"Mantovani","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2024.11.011_bib98","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0165-6147(02)02077-1","article-title":"Statins as anti-inflammatory agents","volume":"23","author":"Weitz-Schmidt","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ymthe.2024.11.011_bib99","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.wco.0000073942.19076.d1","article-title":"Statins as potential therapeutic agents in neuroinflammatory disorders","volume":"16","author":"St\u00fcve","year":"2003","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib100","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(04)16205-3","article-title":"Oral simvastatin treatment in relapsing-remitting multiple sclerosis","volume":"363","author":"Vollmer","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2024.11.011_bib101","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/S0140-6736(13)62242-4","article-title":"Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial","volume":"383","author":"Chataway","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2024.11.011_bib102","doi-asserted-by":"crossref","first-page":"6988","DOI":"10.4049\/jimmunol.180.10.6988","article-title":"Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes","volume":"180","author":"Zhang","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib103","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nchembio.1563","article-title":"Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models","volume":"10","author":"Barmada","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib104","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1016\/j.neurobiolaging.2014.07.026","article-title":"Autophagy regulates amyotrophic lateral sclerosis-linked fused in sarcoma-positive stress granules in neurons","volume":"35","author":"Ryu","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ymthe.2024.11.011_bib105","doi-asserted-by":"crossref","DOI":"10.1038\/srep15701","article-title":"IL-6 Inhibits Starvation-induced Autophagy via the STAT3\/Bcl-2 Signaling Pathway","volume":"5","author":"Qin","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2024.11.011_bib106","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12974-019-1589-y","article-title":"MCP1-CCR2 and neuroinflammation in the ALS motor cortex with TDP-43 pathology","volume":"16","author":"Jara","year":"2019","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.ymthe.2024.11.011_bib107","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40035-023-00380-y","article-title":"Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis","volume":"12","author":"Richardson","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.ymthe.2024.11.011_bib108","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000213762","article-title":"Activation of signal transducer and activator of transcription-3 in the spinal cord of sporadic amyotrophic lateral sclerosis patients","volume":"6","author":"Shibata","year":"2009","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.ymthe.2024.11.011_bib109","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1111\/cns.14161","article-title":"Regulatory T\u00a0cells promote functional recovery after spinal cord injury by alleviating microglia inflammation via STAT3 inhibition","volume":"29","author":"Liu","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ymthe.2024.11.011_bib110","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.cell.2020.09.020","article-title":"TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS\/STING in ALS","volume":"183","author":"Yu","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2024.11.011_bib111","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm.3913","article-title":"Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin","volume":"21","author":"Zenaro","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.11.011_bib112","first-page":"170","article-title":"Raised serum proinflammatory cytokines in Alzheimer's disease with depression","volume":"5","author":"Khemka","year":"2014","journal-title":"Aging Dis."},{"key":"10.1016\/j.ymthe.2024.11.011_bib113","article-title":"Protection of TGF-\u03b21 against neuroinflammation and neurodegeneration in A\u03b21-42-induced Alzheimer's disease model rats","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2024.11.011_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109574","article-title":"IL-17 triggers the onset of cognitive and synaptic deficits in early stages of Alzheimer's disease","volume":"36","author":"Brigas","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2024.11.011_bib115","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.12659\/MSM.904240","article-title":"Increased Levels of Pro-Inflammatory and Anti-Inflammatory Cellular Responses in Parkinson's Disease Patients: Search for a Disease Indicator","volume":"23","author":"Yang","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ymthe.2024.11.011_bib116","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.stem.2018.06.015","article-title":"Th17 Lymphocytes Induce Neuronal Cell Death in a Human iPSC-Based Model of Parkinson's Disease","volume":"23","author":"Sommer","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2024.11.011_bib117","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.bbi.2019.07.026","article-title":"IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease","volume":"81","author":"Liu","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ymthe.2024.11.011_bib118","first-page":"67","article-title":"Altered Gut Microbiome and Intestinal Pathology in Parkinson's Disease","volume":"12","author":"Chiang","year":"2019","journal-title":"J.\u00a0Mov. Disord."},{"key":"10.1016\/j.ymthe.2024.11.011_bib119","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/bs.ai.2021.03.002","article-title":"Modeling a complex disease: Multiple sclerosis-Update 2020","volume":"149","author":"Regen","year":"2021","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib120","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025813118","article-title":"Pro-inflammatory T helper 17 directly harms oligodendrocytes in neuroinflammation","volume":"118","author":"Larochelle","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.11.011_bib121","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.msard.2017.09.003","article-title":"Levels of peripheral Th17 cells and serum Th17-related cytokines in patients with multiple sclerosis: A meta-analysis","volume":"18","author":"Li","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.ymthe.2024.11.011_bib122","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/brain\/awy069","article-title":"T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention","volume":"141","author":"van Langelaar","year":"2018","journal-title":"Brain."},{"key":"10.1016\/j.ymthe.2024.11.011_bib123","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T\u00a0cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2024.11.011_bib124","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.21652","article-title":"T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta","volume":"65","author":"Durelli","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib125","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2023174118","article-title":"Bcl6 controls meningeal Th17-B cell interaction in murine neuroinflammation","volume":"118","author":"Hartlehnert","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.11.011_bib126","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1084\/jem.20132378","article-title":"SIRT1 deacetylates ROR\u03b3t and enhances Th17 cell generation","volume":"212","author":"Lim","year":"2015","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2024.11.011_bib127","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.immuni.2019.04.006","article-title":"Fate-Mapping of GM-CSF Expression Identifies a Discrete Subset of Inflammation-Driving T Helper Cells Regulated by Cytokines IL-23 and IL-1\u03b2","volume":"50","author":"Komuczki","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2024.11.011_bib128","doi-asserted-by":"crossref","first-page":"8042","DOI":"10.3390\/ijms22158042","article-title":"Interleukin-17 and Th17 Lymphocytes Directly Impair Motoneuron Survival of Wildtype and FUS-ALS Mutant Human iPSCs","volume":"22","author":"Jin","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2024.11.011_bib129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2022.06.004","article-title":"Blocking immune cell infiltration of the central nervous system to tame Neuroinflammation in Amyotrophic lateral sclerosis","volume":"105","author":"Garofalo","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ymthe.2024.11.011_bib130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.clim.2013.04.010","article-title":"T helper-17 activation dominates the immunologic milieu of both amyotrophic lateral sclerosis and progressive multiple sclerosis","volume":"148","author":"Saresella","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib131","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1038\/s41598-020-62756-8","article-title":"Peripheral proinflammatory Th1\/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis","volume":"10","author":"Jin","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2024.11.011_bib132","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/brain\/awr074","article-title":"Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis","volume":"134","author":"Beers","year":"2011","journal-title":"Brain."},{"key":"10.1016\/j.ymthe.2024.11.011_bib133","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/wsbm.1187","article-title":"The role of regulatory T\u00a0cells in neurodegenerative diseases","volume":"5","author":"He","year":"2013","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"10.1016\/j.ymthe.2024.11.011_bib134","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.191","article-title":"ROCK2 is a major regulator of axonal degeneration, neuronal death and axonal regeneration in the CNS","volume":"5","author":"Koch","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2024.11.011_bib135","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.4103\/1673-5374.112854","article-title":"Rho kinase: A new target for treatment of cerebral ischemia\/reperfusion injury","volume":"8","author":"Cui","year":"2013","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ymthe.2024.11.011_bib136","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1177\/1073858414554954","article-title":"Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinson's Disease","volume":"21","author":"Labandeira-Garcia","year":"2015","journal-title":"Neuroscientist"},{"key":"10.1016\/j.ymthe.2024.11.011_bib137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.03.008","article-title":"ROCK inhibition in models of neurodegeneration and its potential for clinical translation","volume":"189","author":"Koch","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ymthe.2024.11.011_bib138","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s40478-020-01062-w","article-title":"PINK1\/PARKIN signalling in neurodegeneration and neuroinflammation","volume":"8","author":"Quinn","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ymthe.2024.11.011_bib139","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1038\/ncomms3189","article-title":"Identification of ROCK1 kinase as a critical regulator of Beclin1-mediated autophagy during metabolic stress","volume":"4","author":"Gurkar","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.11.011_bib140","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41467-019-13781-3","article-title":"ROCK inhibitors upregulate the neuroprotective Parkin-mediated mitophagy pathway","volume":"11","author":"Moskal","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.11.011_bib141","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1476-5381.2011.01259.x","article-title":"The Rho kinase inhibitor Fasudil up-regulates astrocytic glutamate transport subsequent to actin remodelling in murine cultured astrocytes","volume":"163","author":"Lau","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib142","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3109\/00207454.2013.877014","article-title":"Intracranial injection of PEG-PEI\/ROCK II-siRNA improves cognitive impairment in a mouse model of Alzheimer's disease","volume":"124","author":"Wen","year":"2014","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.ymthe.2024.11.011_bib143","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.nbd.2014.09.013","article-title":"AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in\u00a0vitro and in\u00a0vivo","volume":"73","author":"Saal","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2024.11.011_bib144","first-page":"1356","article-title":"Technical guidelines for seasonal influenza vaccination in China (2022-2023)","volume":"56","author":"Zhibin","year":"2022","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"10.1016\/j.ymthe.2024.11.011_bib145","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/S2666-5247(21)00267-6","article-title":"Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis","volume":"3","author":"Cromer","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ymthe.2024.11.011_bib146","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.1958","article-title":"Exploring the chemical space of influenza neuraminidase inhibitors","volume":"4","author":"Anuwongcharoen","year":"2016","journal-title":"PeerJ"},{"key":"10.1016\/j.ymthe.2024.11.011_bib147","article-title":"Severe covid-19 pneumonia: pathogenesis and clinical management","volume":"372","author":"Attaway","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ymthe.2024.11.011_bib148","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in Hospitalized Patients with Covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.11.011_bib149","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/cid\/cir398","article-title":"Early Use of Glucocorticoids Was a Risk Factor for Critical Disease and Death From pH1N1 Infection","volume":"53","author":"Han","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ymthe.2024.11.011_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106210","article-title":"The role of JAK\/STAT signaling pathway and its inhibitors in diseases","volume":"80","author":"Xin","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib155","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.4049\/jimmunol.0902819","article-title":"Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050","volume":"184","author":"Fridman","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib159","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1182\/blood-2016-11-731604","article-title":"Does ruxolitinib prolong the survival of patients with myelofibrosis?","volume":"129","author":"Cervantes","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.11.011_bib161","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.4049\/jimmunol.1201348","article-title":"Preclinical characterization of GLPG0634, a selective inhibitor of JAK1, for the treatment of inflammatory diseases","volume":"191","author":"Van Rompaey","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib163","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1002\/art.39801","article-title":"A Phase IIb Study of ABT-494, a Selective JAK-1 Inhibitor, in Patients With Rheumatoid Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Therapy","volume":"68","author":"Kremer","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib165","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/annrheumdis-2015-208279","article-title":"Efficacy and safety of the oral Janus kinase inhibitor peficitinib (ASP015K) monotherapy in patients with moderate to severe rheumatoid arthritis in Japan: a 12-week, randomised, double-blind, placebo-controlled phase IIb study","volume":"75","author":"Takeuchi","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ymthe.2024.11.011_bib176","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1517\/13543784.2013.778242","article-title":"Fasudil and its analogs: a new powerful weapon in the long war against central nervous system disorders?","volume":"22","author":"Chen","year":"2013","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ymthe.2024.11.011_bib190","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ajo.2022.11.017","article-title":"Ripasudil-Brimonidine Fixed-Dose Combination vs Ripasudil or Brimonidine: Two Phase 3 Randomized Clinical Trials","volume":"248","author":"Tanihara","year":"2023","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib191","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2023.2949","article-title":"Symptomatic Netarsudil-Induced Verticillata","volume":"141","author":"Rivera","year":"2023","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib180","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1200\/JCO.20.02754","article-title":"ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease","volume":"39","author":"Jagasia","year":"2021","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib151","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nbt1358","article-title":"A quantitative analysis of kinase inhibitor selectivity","volume":"26","author":"Karaman","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib152","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1124\/dmd.113.054940","article-title":"The pharmacokinetics, metabolism, and clearance mechanisms of tofacitinib, a janus kinase inhibitor, in humans","volume":"42","author":"Dowty","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ymthe.2024.11.011_bib153","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s40264-016-0430-0","article-title":"Benefit and Risk of Tofacitinib in the Treatment of Rheumatoid Arthritis: A Focus on Herpes Zoster","volume":"39","author":"Yamaoka","year":"2016","journal-title":"Drug Saf."},{"key":"10.1016\/j.ymthe.2024.11.011_bib154","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.tips.2020.06.007","article-title":"Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19","volume":"41","author":"Luo","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ymthe.2024.11.011_bib156","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s40265-017-0723-3","article-title":"Baricitinib: First Global Approval","volume":"77","author":"Markham","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.ymthe.2024.11.011_bib157","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cell.2020.11.007","article-title":"Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques","volume":"184","author":"Hoang","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2024.11.011_bib158","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1172\/JCI141772","article-title":"Baricitinib restrains the immune dysregulation in patients with severe COVID-19","volume":"130","author":"Bronte","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2024.11.011_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106023","article-title":"Side effects of ruxolitinib in patients with SARS-CoV-2 infection: Two case reports","volume":"56","author":"Gaspari","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ymthe.2024.11.011_bib162","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1053\/j.gastro.2017.06.040","article-title":"Filgotinib in Crohn's Disease: JAK Is Back","volume":"153","author":"Danese","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ymthe.2024.11.011_bib164","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1002\/art.39808","article-title":"Efficacy and Safety of ABT-494, a Selective JAK-1 Inhibitor, in a Phase IIb Study in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate","volume":"68","author":"Genovese","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib166","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jphs.2016.12.001","article-title":"A novel JAK inhibitor, peficitinib, demonstrates potent efficacy in a rat adjuvant-induced arthritis model","volume":"133","author":"Ito","year":"2017","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.ymthe.2024.11.011_bib167","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/bjd.13745","article-title":"A phase 2a randomized, double-blind, placebo-controlled, sequential dose-escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate-to-severe psoriasis","volume":"173","author":"Papp","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib168","article-title":"The use of Janus Kinase inhibitors in hospitalized patients with COVID-19: Systematic review and meta-analysis","volume":"11","author":"Wijaya","year":"2021","journal-title":"Clin. Epidemiol. Glob. Health"},{"key":"10.1016\/j.ymthe.2024.11.011_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115162","article-title":"JAK inhibition as a new treatment strategy for patients with COVID-19","volume":"202","author":"Huang","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib170","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1038\/s41375-021-01266-6","article-title":"JAK-inhibitors for coronavirus disease-2019 (COVID-19): a meta-analysis","volume":"35","author":"Chen","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.ymthe.2024.11.011_bib171","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1165\/rcmb.2018-0328OC","article-title":"STAT3 Regulates the Onset of Oxidant-induced Senescence in Lung Fibroblasts","volume":"61","author":"Waters","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib172","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1096\/fj.15-273953","article-title":"STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation","volume":"30","author":"Pedroza","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2024.11.011_bib173","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/annrheumdis-2013-204256","article-title":"Inhibition of casein kinase II reduces TGF\u03b2 induced fibroblast activation and ameliorates experimental fibrosis","volume":"74","author":"Zhang","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ymthe.2024.11.011_bib174","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1124\/pr.119.018440","article-title":"Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution","volume":"72","author":"Bharadwaj","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ymthe.2024.11.011_bib175","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1021\/acs.jmedchem.5b00308","article-title":"Design, synthesis, and biological evaluation of novel, highly active soft ROCK inhibitors","volume":"58","author":"Boland","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ymthe.2024.11.011_bib177","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-med-051914-022120","article-title":"Rho Kinases in Autoimmune Diseases","volume":"67","author":"Pernis","year":"2016","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ymthe.2024.11.011_bib178","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00018-009-0189-x","article-title":"Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity","volume":"67","author":"Hahmann","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymthe.2024.11.011_bib179","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ejmech.2019.06.089","article-title":"Potently inhibiting cancer cell migration with novel 3H-pyrazolo[4,3-f]quinoline boronic acid ROCK inhibitors","volume":"180","author":"Dayal","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ymthe.2024.11.011_bib181","doi-asserted-by":"crossref","first-page":"16814","DOI":"10.1073\/pnas.1414189111","article-title":"Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T\u00a0cells via STAT3-dependent mechanism","volume":"111","author":"Zanin-Zhorov","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.11.011_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104871","article-title":"ROCK2 inhibition: A futuristic approach for the management of Alzheimer's disease","volume":"142","author":"Mani","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ymthe.2024.11.011_bib183","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tips.2010.12.006","article-title":"Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease","volume":"32","author":"Zhou","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ymthe.2024.11.011_bib184","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1158\/1078-0432.CCR-20-0700","article-title":"First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors","volume":"26","author":"McLeod","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2024.11.011_bib185","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41582-021-00549-x","article-title":"Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus","volume":"17","author":"Bettcher","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib186","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s11481-015-9612-2","article-title":"T Cells-Protective or Pathogenic in Alzheimer's Disease?","volume":"10","author":"McManus","year":"2015","journal-title":"J.\u00a0Neuroimmune Pharmacol."},{"key":"10.1016\/j.ymthe.2024.11.011_bib187","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bbi.2010.12.004","article-title":"Increased activity of Th-17 and Th-9 lymphocytes and a skewing of the post-thymic differentiation pathway are seen in Alzheimer's disease","volume":"25","author":"Saresella","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ymthe.2024.11.011_bib188","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1158\/1078-0432.CCR-12-0284","article-title":"Molecular pathways: Jak\/STAT pathway: mutations, inhibitors, and resistance","volume":"19","author":"Quint\u00e1s-Cardama","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2024.11.011_bib189","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1182\/blood-2015-10-678706","article-title":"Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism","volume":"127","author":"Flynn","year":"2016","journal-title":"Blood"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162400738X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162400738X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:29:37Z","timestamp":1783020577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500162400738X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":191,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S152500162400738X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.11.011","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel insights into the ROCK-JAK-STAT signaling pathway in upper respiratory tract infections and neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}